Overview

Stinson's patent attorneys advise chemical, pharmaceutical and biotechnology companies on every aspect of intellectual property law, including patent protection and strategy, enforcement and client counseling. We also defend clients against claims of infringement. We seek to understand the underlying commercialization aspects of our clients' technologies to develop specific intellectual property and business objectives. In addition to having the legal experience to protect critical intellectual property assets, many of our patent attorneys have advanced degrees and industry experience that provide for a deeper understanding of the science underlying our clients' discoveries.

Capabilities

  • Patent application preparation and prosecution
  • Patentability analysis
  • Preparing opinions for freedom-to-operate, invalidity, and non-infringement
  • Due diligence analysis
  • Patent landscape analysis
  • Design around
  • Post grant proceedings at the USPTO
  • Foreign opposition proceedings
  • Litigation
  • License agreements

Chemical

Our attorneys provide services over a wide range of chemical technologies including pharmaceuticals, organic chemistry, inorganic chemistry, analytical chemistry, biochemistry, polymer science, material science and chemical engineering. Representative subject matter includes:

  • Absorbent materials
  • Adhesives
  • Biosensors
  • Coatings
  • Colors and Dyes
  • Detergents
  • Energy storage
  • Environmental remediation
  • Food products
  • Lubricants
  • Microencapsulation
  • Nanotechnology
  • Nutritionals
  • Oil and Gas chemical agents
  • Pesticides
  • Plastics and Polymers
  • Skin care
  • Solar panels

Pharmaceutical

Representative subject matter includes:

  • Animal health
  • Drug delivery
  • Drug conjugates and formulations
  • Microencapsulation
  • Nanotechnology
  • Polymer drugs
  • Small molecule drugs
  • Vaccines

Biotechnology

We provide patent preparation and prosecution, counseling and litigation services over a wide range of biotechnologies including biological therapies, diagnostics, biologically-produced molecules and agriculture both in the U.S. and abroad. Representative subject matter includes:

  • Antibodies
  • Aptamers
  • Bioactive peptides
  • Biofuels
  • Biomarkers
  • Biosensors
  • Cell Culture
  • Cell therapies
  • CRISPR-Cas gene editing
  • Diagnostics
  • DNA
  • Enzymes
  • Gene editing
  • Gene therapies
  • Immunoassays
  • Microencapsulation
  • Microfluidics
  • Molecular cloning
  • Nutritionals
  • Recombinant protein technology
  • RNA
  • Skin care
  • Tissue engineering
  • Transgenic animals
  • Transgenic cells/microorganisms
  • Transgenic plants


Team

Team

News & Insights

Jump to Page

We use cookies on our website to improve functionality and performance, analyze website traffic and enable social media features. By continuing to use our website, you agree to our use of cookies. For more information, please see our Cookie Policy.